Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

1(20.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 1(1)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07269288Not Yet Recruiting

The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke

Role: lead

NCT06751264Not ApplicableNot Yet Recruiting

Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance

Role: lead

NCT05259956Not ApplicableCompleted

Trial on Two Treatments for Adolescent Idiopathic Scoliosis

Role: lead

NCT03851497Completed

Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer

Role: collaborator

NCT03010735Phase 2Completed

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

Role: collaborator

NCT03010696Completed

The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)

Role: collaborator

NCT02042690Phase 3Completed

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients

Role: collaborator

NCT01677013Phase 1Completed

Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus

Role: lead

NCT02350010Unknown

Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing

Role: collaborator

All 9 trials loaded